Sathyanarayanan Krishnamurthy looks at the potential impact of Pharma 4.0 on product development and regulatory operations.
Sathyanarayanan Krishnamurthy
Advertisement
Sathyanarayanan Krishnamurthy is an artwork and package in expert and specialist with over 15+ years of experience in Life Sciences Industry that spans across, Operations Management; Client servicing and People Management for Biopharma (Innovator and Generic) and Consumer Business.
Articles by Sathyanarayanan Krishnamurthy
Advertisement
Latest Updated Articles
Pharma 4.0: Redefining Product Development and Regulatory OperationsPublished: September 17th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
2
FDA Announces New Plausible Mechanism Pathway
3
Roundup: Ovid Therapeutics and Metagenomi Announce 2025 Third Quarter Results and Leadership Updates
4
WeightWatchers to Offer Novo Nordisk’s Oral Wegovy, if Approved Next Year
5
